SHLTN Stock Overview
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
SHL Telemedicine Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF5.36 |
| 52 Week High | CHF11.50 |
| 52 Week Low | CHF4.92 |
| Beta | 0.32 |
| 1 Month Change | -5.13% |
| 3 Month Change | -13.55% |
| 1 Year Change | -40.44% |
| 3 Year Change | -50.83% |
| 5 Year Change | -8.38% |
| Change since IPO | -86.93% |
Recent News & Updates
Recent updates
We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope
Dec 01
Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?
Oct 28Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?
Jun 23SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Mar 05Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 12What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?
Jan 21Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%
Jan 04
What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?
Dec 01Shareholder Returns
| SHLTN | CH Healthcare | CH Market | |
|---|---|---|---|
| 7D | -2.5% | -1.1% | -1.1% |
| 1Y | -40.4% | -8.3% | -1.8% |
Return vs Industry: SHLTN underperformed the Swiss Healthcare industry which returned -8% over the past year.
Return vs Market: SHLTN underperformed the Swiss Market which returned -2.8% over the past year.
Price Volatility
| SHLTN volatility | |
|---|---|
| SHLTN Average Weekly Movement | 9.0% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.4% |
| 10% least volatile stocks in CH Market | 1.9% |
Stable Share Price: SHLTN's share price has been volatile over the past 3 months.
Volatility Over Time: SHLTN's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 402 | Erez Nachtomy | www.shl-telemedicine.com |
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead ECG transmitter device; Cardio’B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate.
SHL Telemedicine Ltd. Fundamentals Summary
| SHLTN fundamental statistics | |
|---|---|
| Market cap | CHF87.86m |
| Earnings (TTM) | -CHF2.11m |
| Revenue (TTM) | CHF52.10m |
1.7x
P/S Ratio-41.5x
P/E RatioIs SHLTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHLTN income statement (TTM) | |
|---|---|
| Revenue | US$57.10m |
| Cost of Revenue | US$32.03m |
| Gross Profit | US$25.08m |
| Other Expenses | US$27.40m |
| Earnings | -US$2.32m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Apr 17, 2024
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 43.92% |
| Net Profit Margin | -4.06% |
| Debt/Equity Ratio | 16.9% |
How did SHLTN perform over the long term?
See historical performance and comparison